Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

South Korean regulator publishes final ruling on Samsung BioLogics’ accounting violations

pharmaceutical-technologyNovember 15, 2018

Tag: Samsung Biologics , South Korean , SFC

PharmaSources Customer Service